People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroEM Therapeutics, Inc. | — | Pharma | Seed | $2.3M | $6.2M | 2024 |
| International Screening Solutions, Inc. | — | Other Technology | Seed | $1.9M | $63.4M | 2018 |
Chuck Papageorgiou at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chuck Papageorgiou on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Gordon | 1 | 5 |
| MICHAEL R. GREENLEE | 1 | 1 |
| KENNETH R. KUNSMAN | 1 | 1 |
| THOMAS R. CARDY | 1 | 1 |
| MICHAEL R. REENE | 1 | 1 |
| MICHAEL R. ABBAEI | 1 | 1 |
| MARK R. DOBSON | 1 | 1 |
| PATRICIA DOBSON | 1 | 1 |
| ERIC BEACH | 1 | 1 |
| Mitch Larimore | 1 | 1 |
| G. CHRIS CALLAS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.